Stay updated on Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page adds the term 'Squamous cell carcinoma of the head and neck' and includes a new Resources entry for the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T04:58:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces v3.4.3 on the page. No visible changes to study details, eligibility criteria, or outcomes are evident in the current content.
    Difference
    0.1%
    Check dated 2026-03-18T18:02:43.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page header/footer.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Minor administrative updates: the page revision is updated to v3.4.2 and the previous funding/status notices are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:16:44.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Notices about government funding lapse and NIH operating status were added, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:30:14.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI updates include showing the glossary option, adding the label 'Last Update Submitted that Met QC Criteria,' capitalization adjustment for 'No FEAR Act Data,' and a new revision reference (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:45:02.000Z thumbnail image

Stay in the know with updates to Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.